Viewing nowCombinationAmiget 10/20 Milligrams
Ezetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
Daewon Biotech Co., Ltd.

MFDS item code 202101624 · Approved 2021.02.18 · Insurance code 057600850
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
This medication is used as an adjunct to dietary changes to improve cholesterol and lipid levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It specifically lowers total cholesterol, LDL-cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol levels while increasing HDL cholesterol levels to support vascular health. In patients with homozygous familial hypercholesterolemia, it is administered as an adjunct to other lipid-lowering treatments or when other treatments are ineffective. This medication has been studied for specific types of dyslipidemia and is used when responses to appropriate dietary changes and non-drug treatments are insufficient. Before administration, it is essential to identify and treat other underlying diseases, and patients' lipid levels should be monitored regularly to ensure treatment efficacy. This medication helps reduce cardiovascular risks caused by hypercholesterolemia.
This medication should be administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medication. The dose should be adjusted according to the patient’s baseline LDL cholesterol level, the recommended treatment goal, and the patient’s response. Primary hypercholesterolemia The dosage range is 10/10mg∼10/80mg once daily. The recommended initial dose is 10/10mg or 10/20mg once daily. For patients requiring a greater reduction in LDL cholesterol (55% or more), an initial dose of 10/40mg once daily is recommended. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly. Homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg or 10/80mg once daily. Administer this medication as an adjunct to other lipid-lowering therapy (e.g., LDL apheresis), or when other lipid-lowering therapy is not useful.
This medication may cause abnormal reactions in the muscles, and caution is needed, particularly in patients at risk for acute myopathy or rhabdomyolysis. If symptoms such as muscle pain, muscle cramps, muscle weakness, or fatigue occur during this medication, consult a doctor immediately. Additionally, as this medication may impact liver function, liver function tests should be performed before administration, and regular liver function tests should be conducted during treatment. Patients with liver diseases or abnormally elevated liver enzyme levels should not take this medication. Co-administration with certain drugs may increase the risk of side effects due to interactions, so any current medications should indeed be communicated to the doctor or pharmacist. Pregnant women or women who may become pregnant, as well as breastfeeding women, should not take this medication, and women of childbearing age should use appropriate contraception while taking this medication. Caution is also advised for patients who excessively consume alcohol or have a history of liver disease, and older adults are at a higher risk for myopathy. Efficacy and safety have not been established in children, so it is not recommended. In cases of overdose, as there is no specific antidote, appropriate treatment and supportive care should be given according to symptoms while monitoring liver function and muscle condition. This medication should be kept out of reach of children, and it is not advisable to transfer it into another container.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to protect it from air and moisture. It is best to store it at room temperature between 1°C and 30°C.
White oblong film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
Daewon Biotech Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 86.8mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 10.9mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationAtorvastatin Calcium 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.